There are many bad actors involved in Abeona who have a long history of shareholder value destruction
We initially exposed Abeona for the low-quality biotech it is back in December 2016. We recommend readers refamiliarize themselves with our two reports on the company (here and here). To quickly summarize the original report:
- Abeona’s Chairman Steven Rouhandeh has presided over many shareholder wipeouts over his career as a stock promoter. Despite these bad outcomes, Rouhandeh has personally profited to the tune of millions of dollars as shareholders in many cases lost all of their